Fundraising Fox

Harmonix Fund

Venture capital

La Quinta · Pre-Seed–Late Stage · 7 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Harmonix invests at the early stage in companies working to advance human health and improve quality of life through meaningful innovation. It partners with founders building in healthcare, life sciences, and deep tech, backing pioneering technologies aimed at transformative change. Its multidisciplinary team of entrepreneurs, scientists, operators, and industry experts offers technical, operating, industry, and advisory support to help companies accelerate and commercialize the next generation of technological advances. Investment decisions are guided by an evidence-based due diligence framework used to assess prospective companies.

Source: firm website, verified Aug 3, 2026.

Stage
Pre-Seed–Late Stage
HQ
La Quinta, US
Tracked investments
36

Team · 7 people

from the firm's website
Cofield Mundi· Partnerin

Cofield Mundi is Chief Operating Officer and partner at Harmonix, providing strategic support to the fund and its 40+ companies. She has over 30 years of experience in operational and business leadership roles across verticals including interior lifestyle brands, import/export, and entertainment, having led teams of up to 45 people. She grew up in South Africa and has lived in Botswana, Kenya, London, and the United States, and is also a recording artist previously signed to Sony and Universal Music.

Krish Ramadurai· Partnerin
Maximilian Winter· General Partnerin

Maximilian Winter is a fourth-generation entrepreneur from a German family business with over 70 years of history, and has experience running a family enterprise, family office, and philanthropic foundation. At Harmonix, he focuses on investing in scalable scientific breakthroughs, with particular interest in transforming healthcare and advancing human health and infrastructure through technology.

Dave Messina· Advisorin
Erez Podoly· Advisorin
Michael Fenn· Advisorin

Michael Fenn is Director of External Innovation at Dewpoint Therapeutics and previously served as Director of Healthcare & Life Sciences at Harvard Innovation Labs, where he co-led planning of Life Lab Longwood at Harvard Medical School. He was formerly an Assistant Professor of Biomedical Engineering and Director of the Center for Medical Materials & Biophotonics at the Florida Institute of Technology. He holds a Ph.D. in Biomedical Engineering, an M.S. in Materials Science and Engineering, and a B.S. in Chemistry/Biochemistry, all from the University of Florida, and has cofounded and advised multiple startups.

Paul McEwan· Advisorin

Investments · 36 tracked

founders shown can be your intro path
Abalone Bio
Aether
Ancilia Therapeutics
Atlas
Attivare
Auransa
Babylon Microfarms
Bioz
Caresyntax
Dermasensor
GEN1E Lifesciences
Halo Industries
Insilico Medicine
Juvena Therapeutics
Loft Orbital
Nelumbo
Paradromics
Pathology Watch
PolySpectra
Pragma Bio
Precipoint
Qu Biologics
Rad AI
Sana health
SentiAR
Sorcero
spotlight-image
Strateos
Tarana
Terramera
Trials AI
Unlimited Tomorrow
Viscient Biosciences
Visicell
Volumetric
xCures

Frequently asked questions

What stage does Harmonix Fund invest at?
Harmonix Fund invests at the Pre-Seed, Seed, Series A, Late Stage stages.
What sectors does Harmonix Fund focus on?
Harmonix Fund focuses on Biotech, Deep Tech, Digital Health, Healthtech, Longevity, Medical Devices.
Where is Harmonix Fund located?
Harmonix Fund is headquartered in La Quinta, US.

Media · Podcasts & interviews

featuring the team

Maximilian Winter shares the mission at Harmonix Fund #deeptech #lifescience #healthcare #innovation - YouTube

VC10X with Prashant Choubey · Maximilian Winter

Science - Driven VC Fund, Maximilian Winter, GP & Krish Ramadurai, Partner at Harmonix fund - YouTube

VC10X with Prashant Choubey · Maximilian Winter

Images

Harmonix Fund photoHarmonix Fund photoHarmonix Fund photoHarmonix Fund photoHarmonix Fund photoHarmonix Fund photo

Similar investors

Featured in lists